AB-200-ARC-SPF
N/A
Report date: 2022/12/15 11:14:47
NME
Base Information
Drug NameAB-200-ARC-SPF
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnjon Biologics
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A